Hypertension Drugs: Medicare Part D Spending

What Medicare Part D spent on the medicines used for this topic, how many people used them, and the cost per unit.

Each number has its full source under its own list below.

Medicare Part D spending

138 medicines (calendar year 2024). Medicines whose FDA label lists a use on this topic, by what Part D spent on them in total. Many medicines have more than one use, so the totals are not added up.

At the source
  1. 1LumiganBimatoprost · $96.72 per unit$647.2 million
  2. 2Metoprolol SuccinateMetoprolol Succinate · $0.18 per unit$456 million
  3. 3Losartan PotassiumLosartan Potassium · $0.13 per unit$355.2 million
  4. 4Amlodipine BesylateAmlodipine Besylate · $0.08 per unit$315.7 million
  5. 5LisinoprilLisinopril · $0.09 per unit$252.9 million
  6. 6LokelmaSodium Zirconium Cyclosilicate · $26.66 per unit$239 million
  7. 7XywavSodium,Calcium,Mag,Pot Oxybate · $37.03 per unit$210.5 million
  8. 8ValsartanValsartan · $0.34 per unit$127.7 million
  9. 9EpinephrineEpinephrine · $99.63 per unit$119.3 million
  10. 10Metoprolol Tartrate*Metoprolol Tartrate · $0.06 per unit$107 million
  11. 11Diltiazem 24hr ER (Cd)Diltiazem HCl · $0.39 per unit$103.3 million
  12. 12Hydralazine HCl*Hydralazine HCl · $0.09 per unit$81.7 million
  13. 13HydrochlorothiazideHydrochlorothiazide · $0.06 per unit$81.2 million
  14. 14Nebivolol HClNebivolol HCl · $0.79 per unit$80.4 million
  15. 15Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide · $0.18 per unit$79.5 million

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

Benchmarks on hypertension

Countries side by side on public measures for this topic.

All benchmarks

US drug spending on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.